Position in IFRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$336,000
New position
Shares Held
150,000
first reported quarter
Ownership
0.102%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#30
of 62 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026MYDA Advisors LLC holds $47,243,871 across 14 Biotechnology names. IFRX ranks #10 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
|
1,150,000 | $17,112,000 | |
| 2 | MANE |
Veradermics, Inc
|
100,000 | $12,294,000 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
240,000 | $6,292,800 | |
| 4 | EYPT |
EyePoint, Inc.
|
250,000 | $3,575,000 | |
| 5 | BNTC |
Benitec Biopharma Inc.
|
250,000 | $3,345,000 | |
| 6 | PROK |
Prokidney Corp.
|
640,775 | $1,307,181 | |
| 7 | IMTX |
Immatics N.V.
|
120,000 | $1,215,600 | |
| 8 | INSM |
INSMED Inc
|
7,000 | $746,340 |
All Filings in IFRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $336,000 | 150,000 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||